Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis
- PMID: 18781287
- DOI: 10.1007/s12325-008-0096-9
Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis
Abstract
Introduction: Azithromycin, a broad-spectrum antibiotic with potent anti-inflammatory activities, has the potential to effectively treat blepharitis, an inflammatory disease of the eyelid with abnormal eyelid flora as an etiologic determinant. The present study compared the efficacy of topical azithromycin ophthalmic solution 1% (AzaSite; Inspire Pharmaceuticals, Inc, NC, USA) combined with warm compresses (azithromycin group) to warm compresses alone (compress group) in patients with posterior blepharitis.
Methods: Twenty-one patients diagnosed with posterior blepharitis were randomized in an open-label study to receive either azithromycin plus warm compresses (10 patients), or compresses alone (11 patients). All patients were instructed to apply compresses to each eye for 5-10 minutes twice daily for 14 days. Each eye in the azithromycin group also received azithromycin solution (1 drop) twice daily for the first 2 days followed by once daily for the next 12 days. Patients were evaluated at study initiation (visit 1) and at end of treatment (visit 2) for the severity of five clinical signs: eyelid debris, eyelid redness, eyelid swelling, meibomian gland (MG) plugging, and the quality of MG secretion. At visit 2, patients also rated their degree of overall symptomatic relief.
Results: Twenty patients completed the study. At visit 2, patients in the azithromycin group demonstrated significant improvements in MG plugging, MG secretions, and eyelid redness as compared with the compress group. In the azithromycin group, MG plugging resolved completely in three patients and MG secretion returned to normal in two patients; no such results were seen in the compress group. Furthermore, a higher percentage of patients in the azithromycin group rated overall symptomatic relief as excellent or good. Visual acuity measurements and biomicroscopic evaluation revealed no ocular safety issues.
Conclusion: Azithromycin ophthalmic solution in combination with warm compresses provided a significantly greater clinical benefit than warm compresses alone in treating the signs and symptoms of posterior blepharitis.
Similar articles
-
Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis.Cornea. 2010 Aug;29(8):871-7. doi: 10.1097/ICO.0b013e3181ca38a0. Cornea. 2010. PMID: 20508503
-
Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis.Clin Exp Optom. 2011 Mar;94(2):200-6. doi: 10.1111/j.1444-0938.2010.00540.x. Epub 2010 Nov 17. Clin Exp Optom. 2011. PMID: 21083761 Clinical Trial.
-
Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis.Curr Med Res Opin. 2011 Jan;27(1):171-8. doi: 10.1185/03007995.2010.539603. Epub 2010 Dec 7. Curr Med Res Opin. 2011. PMID: 21138337 Clinical Trial.
-
Current evidence for topical azithromycin 1% ophthalmic solution in the treatment of blepharitis and blepharitis-associated ocular dryness.Int Ophthalmol Clin. 2011 Fall;51(4):43-52. doi: 10.1097/IIO.0b013e31822d6af1. Int Ophthalmol Clin. 2011. PMID: 21897139 Review. No abstract available.
-
[Pediatric ocular rosacea effectively treated with topical 1.5% azithromycin eye drops].Ophthalmologe. 2021 Jan;118(1):68-73. doi: 10.1007/s00347-020-01279-z. Ophthalmologe. 2021. PMID: 33296015 Review. German.
Cited by
-
Efficacy of azithromycin 1.5% eye drops in childhood ocular rosacea with phlyctenular blepharokeratoconjunctivitis.J Ophthalmic Inflamm Infect. 2013 Feb 22;3(1):38. doi: 10.1186/1869-5760-3-38. J Ophthalmic Inflamm Infect. 2013. PMID: 23514194 Free PMC article.
-
Diagnosis and management of blepharitis: an optometrist's perspective.Clin Optom (Auckl). 2016 Aug 8;8:71-78. doi: 10.2147/OPTO.S84795. eCollection 2016. Clin Optom (Auckl). 2016. PMID: 30214351 Free PMC article. Review.
-
Interventions for chronic blepharitis.Cochrane Database Syst Rev. 2012 May 16;2012(5):CD005556. doi: 10.1002/14651858.CD005556.pub2. Cochrane Database Syst Rev. 2012. PMID: 22592706 Free PMC article.
-
Comparison of therapeutic effects of topical azithromycin solution and systemic doxycycline on posterior blepharitis.Int J Ophthalmol. 2016 Jul 18;9(7):1016-9. doi: 10.18240/ijo.2016.07.14. eCollection 2016. Int J Ophthalmol. 2016. PMID: 27500111 Free PMC article.
-
Azithromycin Protects Retinal Glia Against Oxidative Stress-Induced Morphological Changes, Inflammation, and Cell Death.ACS Bio Med Chem Au. 2022 Jul 12;2(5):499-508. doi: 10.1021/acsbiomedchemau.2c00013. eCollection 2022 Oct 19. ACS Bio Med Chem Au. 2022. PMID: 37101900 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical